Identification of tumor size as the only factor associated with nondiagnostic biopsies in patients with small renal masses

• Published in: Canadian Urological Association journal 2020-05, Vol.14 (5), p.E220
• Main Authors: Gillis, Charlie J, Rendon, Ricardo, MacDonald, Landan P, Jewett, Michael A S, French, Christopher, Ajzenberg, Henry, Almatar, Ashraf, Abdolell, Mohammed, Organ, Michael
• Format: Article
• Language: English
• Subjects: Cancer; Care and treatment; Medical research
• ISSN: 1911-6470; 1920-1214
• DOI: 10.5489/cuai.6103

As greater numbers of small renal masses (SRMs) are discovered incidentally, renal tumor biopsy (RTB) is an increasingly recognized step for the management of these lesions, ideally for the prevention of surgical overtreatment for benign disease. While the diagnosis can often be obtained preoperatively by RTB, indeterminate results create greater difficulty for patients and clinicians. This study examines a series of RTBs, identifying the portion of these that were able to yield a diagnosis, and correlates patient factors, including RENAL and PADUA scoring, with the outcome of a non-diagnostic result. Patients were identified as having undergone RTB at the Princess Margaret Cancer Centre in Ontario, Canada, between January 2000 and December 2009. Data was compiled from these 423 patients and analyzed using CART methodology to determine the level of association between various patient and tumor factors and the outcome of a non-diagnostic biopsy. Tumor size was further used to develop a classification tree to describe the prediction of a non-diagnostic biopsy. Of these 423 patients undergoing RTB, 66 (16%) resulted in a non-diagnostic biopsy. The only patient or tumor factor that was found to be associated with a non-diagnostic outcome was mass size, where small masses (1.28 cm diameter (86% accuracy, 95% confidence interval [CI] 0.82-0.89). When evaluating SRMs for diagnostic workup, mass size is the only tumor or patient characteristic associated with a non-diagnostic RTB.